logo

RDHL

Redhill Biopharma·NASDAQ
--
--(--)
--
--(--)

RDHL fundamentals

Redhill Biopharma (RDHL) released its earnings on Aug 17, 2023: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Aug 17, 2023
EPS
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,2020
Q2,2020
Q3,2020
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,undefined
Actual
-500-400-500-650-500-600-500-500-30-20-60-1.25
Forecast
-690-137.5-270-346-435-352.8571-474.2857-433.3333-300-20-100
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
+27.54%
-190.91%
-85.19%
-87.86%
-14.94%
-70.04%
-5.42%
-15.38%
+90.00%
0.00%
-500.00%
0.00%
0.00%
0.00%
Revenue
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,undefined
Q2,undefined
Q3,undefined
Q4,undefined
Q1,2020
Q2,2020
Q3,2020
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,undefined
Actual
--------------------1.06M20.90M20.94M21.46M20.57M21.50M21.60M22.10M18.24M18.35M17.55M--3.60M--
Forecast
--------------------4.38M22.99M25.36M26.04M22.70M24.29M24.51M24.09M23.60M21.50M18.50M18.10M----
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-75.88%
-9.10%
-17.42%
-17.59%
-9.37%
-11.46%
-11.89%
-8.25%
-22.73%
-14.68%
-5.12%
0.00%
0.00%
0.00%

Earnings Call